JPS5334771A - Thiazolidine derivative and its preparation - Google Patents

Thiazolidine derivative and its preparation

Info

Publication number
JPS5334771A
JPS5334771A JP10870677A JP10870677A JPS5334771A JP S5334771 A JPS5334771 A JP S5334771A JP 10870677 A JP10870677 A JP 10870677A JP 10870677 A JP10870677 A JP 10870677A JP S5334771 A JPS5334771 A JP S5334771A
Authority
JP
Japan
Prior art keywords
preparation
thiazolidine derivative
thiazolidine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10870677A
Other languages
English (en)
Japanese (ja)
Inventor
Kunaape Berunto
Rangu Hansuuyoohien
Gurantsuaa Erunoruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5334771A publication Critical patent/JPS5334771A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84Naphthothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP10870677A 1976-09-08 1977-09-08 Thiazolidine derivative and its preparation Pending JPS5334771A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762640358 DE2640358A1 (de) 1976-09-08 1976-09-08 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
JPS5334771A true JPS5334771A (en) 1978-03-31

Family

ID=5987411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10870677A Pending JPS5334771A (en) 1976-09-08 1977-09-08 Thiazolidine derivative and its preparation

Country Status (20)

Country Link
US (1) US4174397A (US07494231-20090224-C00006.png)
JP (1) JPS5334771A (US07494231-20090224-C00006.png)
AT (2) AT365181B (US07494231-20090224-C00006.png)
AU (1) AU509651B2 (US07494231-20090224-C00006.png)
BE (1) BE858520A (US07494231-20090224-C00006.png)
CA (1) CA1089458A (US07494231-20090224-C00006.png)
DE (1) DE2640358A1 (US07494231-20090224-C00006.png)
DK (1) DK397777A (US07494231-20090224-C00006.png)
ES (1) ES462065A1 (US07494231-20090224-C00006.png)
FI (1) FI772642A (US07494231-20090224-C00006.png)
FR (1) FR2364219A1 (US07494231-20090224-C00006.png)
GB (1) GB1592272A (US07494231-20090224-C00006.png)
HU (1) HU175751B (US07494231-20090224-C00006.png)
IT (1) IT1084414B (US07494231-20090224-C00006.png)
NL (1) NL7709697A (US07494231-20090224-C00006.png)
NO (1) NO773094L (US07494231-20090224-C00006.png)
NZ (1) NZ185105A (US07494231-20090224-C00006.png)
PT (1) PT67014B (US07494231-20090224-C00006.png)
SE (1) SE7710084L (US07494231-20090224-C00006.png)
ZA (1) ZA775405B (US07494231-20090224-C00006.png)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
JP2002538150A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 多環式チアゾール系および食欲抑制剤としてのその使用
JP2002538101A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用
JP2002538147A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 多環2−アミノジヒドロチアゾール系、その製造方法および医薬としての使用

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210039A (ja) * 1983-05-16 1984-11-28 Kirin Brewery Co Ltd 2−ブロモ−1−テトラロン誘導体およびその用途
ATE141599T1 (de) * 1988-04-28 1996-09-15 Schering Corp Kondensierte polyzyklische verbindungen, zusammenstellungen, verfahren zur herstellung und deren anwendung als paf-antagonistische, antihistaminische und/oder anti-inflammatorische agenzien
DE19736921A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Cyanoindan-1-onen
DE19736922A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Halogenindan-1-onen
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908538A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908536A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908537A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
WO2001032638A1 (de) * 1999-11-05 2001-05-10 Aventis Pharma Deutschland Gmbh Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU781003B2 (en) * 2000-02-23 2005-04-28 Aventis Pharma Deutschland Gmbh 8,8A-dihydro-indeno(1,2-D)thiazole derivatives, substituted in position 8A, a method for their production and their use as medicaments, e.g. anorectic agents
ATE248155T1 (de) 2000-02-26 2003-09-15 Aventis Pharma Gmbh 8,8a-dihydro-indeno 1,2-d)thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
CN106255676B (zh) * 2014-05-15 2019-04-30 富士胶片株式会社 α-溴代苯乙酮化合物的制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
JP2002538150A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 多環式チアゾール系および食欲抑制剤としてのその使用
JP2002538101A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用
JP2002538147A (ja) * 1999-02-26 2002-11-12 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 多環2−アミノジヒドロチアゾール系、その製造方法および医薬としての使用
JP4658332B2 (ja) * 1999-02-26 2011-03-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 多環2−アミノジヒドロチアゾール系、その製造方法および医薬としての使用
JP4728482B2 (ja) * 1999-02-26 2011-07-20 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用

Also Published As

Publication number Publication date
ATA171881A (de) 1984-01-15
HU175751B (hu) 1980-10-28
NL7709697A (nl) 1978-03-10
FR2364219B1 (US07494231-20090224-C00006.png) 1980-06-20
ES462065A1 (es) 1978-06-01
NO773094L (no) 1978-03-09
SE7710084L (sv) 1978-03-09
CA1089458A (en) 1980-11-11
US4174397A (en) 1979-11-13
AT365181B (de) 1981-12-28
ATA643577A (de) 1981-05-15
DE2640358A1 (de) 1978-03-16
BE858520A (fr) 1978-03-08
FR2364219A1 (fr) 1978-04-07
FI772642A (fi) 1978-03-09
AU2865777A (en) 1979-03-15
GB1592272A (en) 1981-07-01
PT67014A (de) 1977-09-30
IT1084414B (it) 1985-05-25
AU509651B2 (en) 1980-05-22
NZ185105A (en) 1979-12-11
DK397777A (da) 1978-03-09
PT67014B (de) 1979-05-14
ZA775405B (en) 1978-07-26

Similar Documents

Publication Publication Date Title
JPS52105162A (en) Phthleic derivatives and preparation thereof
JPS5334771A (en) Thiazolidine derivative and its preparation
IL59567A0 (en) Oxiranylmethyltetrahydropyran derivative and its preparation
JPS5379844A (en) Cyclopentanee11amine and like * and its preparation
HK60184A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
JPS5379841A (en) Aminoosugar derivative * its preparation and use
JPS5289669A (en) Thiazolidine derivatives and preparation thereof
JPS52148061A (en) 66carboxymethyl thiocortisol and derivatives thereof
JPS5312861A (en) Benzimdazole derivative and its preparation
JPS5312858A (en) Preparation of thiazole derivative
GB1519747A (en) 2 - arylpiperazine derivatives and the preparation thereo
JPS5315368A (en) Novel 22phenyllindole derivative and preparation thereof
ZA772931B (en) Thiazole derivatives
JPS52122613A (en) Morphineelike compound and its preparation
JPS5291815A (en) Oxyaldehyde compound and its preparation
JPS5346977A (en) 55secondary alkylidenehydantoin and its preparation
JPS52100480A (en) Substituted ppaminophenyllasstriazinedione and its preparation
JPS52133981A (en) 22iminothiazolidine and thiazoline derivatives
JPS52116462A (en) 22oxoopyrrolidine derivative and preparation thereof
GB1543276A (en) Thiazole derivatives
JPS5312863A (en) Benzodithiolan derivative and its preparation
JPS52118459A (en) 22furanone derivative and preparation thereof
JPS5340762A (en) Novel 33hydroxyypyrrolinee22one derivative and its preparation
GB1540347A (en) 4-pyridyl-formimidoylglycyl-d-phenyl-glycine and derivatives
JPS5291863A (en) Novel 22nitroimidazole derivatives and preparation thereof